BridgeBio Pharma, Inc. (BBIO)
25 filings available.
Loading activity recap...
Loading insider activity...
Loading institutional activity...
Loading fund comparison...
Loading contract awards...
Loading activity heatmap...
Full Timeline
Every tracked SEC filing, congressional trade, 13F/N-PORT holding change, lobbying disclosure, government contract award, SEC enforcement action, and pay-vs-performance filing for BBIO, merged into one feed.
Loading timeline...
Get instant alerts the moment BBIO files, trades, or shows up in Congress, 13F, or lobbying data — right on your phone.
Get the app →Recent filings
- BridgeBio Pharma CEO Neil Kumar Sells $691K in Common Stock Under 10b5-1 Plan4Sep 21, 2026Filed by Kumar NeilSale · 10,000 shares · $691K
- BridgeBio Pharma Announces Agreement with U.S. Government to Expand Medicine Access8-KAug 31, 2026
Filers on record
Kumar NeilFirst tracked sale